Alzheimer’s disease (AD) has been reported to cause an increased production of hyaluronic acid (HA), chondroitin sulfate proteoglycans (CSPGs), and tenascin, and a reduction in the levels of reelin [27]. This evidence concerns the gene RELN and Alzheimer disease.